Regulating the expression of CD80/CD86 on dendritic cells to induce immune tolerance after xeno-islet transplantation
- PMID: 26879762
- DOI: 10.1016/j.imbio.2016.02.002
Regulating the expression of CD80/CD86 on dendritic cells to induce immune tolerance after xeno-islet transplantation
Abstract
Background: Antigen present cells (APCs) have been demonstrated to play dual roles in immune tolerance. Recently, compelling evidence indicates that APCs that express CD80, but not CD86 can protect allograft. We investigated whether modulation of CD80 in dendritic cells (DCs) offer protection for xeno-islets.
Methods: In vitro, isolated mature murine DCs received untransfection, transfection with CD86 siRNA or negative control siRNA. The DCs were used in mixed lymphocyte reaction in which rat islets and murine splenocytes were further added. On day 3 of co-culturing, the proliferation of lymphocytes was measured and interleukin (IL)-2, IL-4, IL-10, transforming growth factor β (TGF-β), interferon γ (INF-γ) and indoleamine 2,3-dioxygenase (IDO) from the supernatants were determined. Islets viability and function were also assessed. In vivo, streptozotocin-induced diabetic mice underwent rat islets transplantation were pre-treated with above DCs. At designated time, xeno-islets were subjected to histopathology, immunohistochemistry, survival time and functional tests. Peripheral blood T lymphocyte profiles were also examined.
Results: CD86-silenced-DCs had unchanged expression of CD80 and significantly suppressed the proliferation of lymphocytes. CD86-silenced-DCs simultaneously reduced IL-2 and INF-γ and increased IL-10, TGF-β and IDO, while had minimal effect on IL-4. The CD86-silenced-DCs also improved cell viability and function of xeno-islets when compared to untransfection and transfection control groups. In xeno-islets transplanted diabetic mice, transfer of CD86-silenced-DCs resulted in improved histopathology and dramatically prolonged survival time of the islets. These effects were also mirrored by the functional tests. Further analysis revealed that CD86-silenced-DCs had up-regulated levels of CD4(+)CD25(+)T cells in the peripheral blood compared to the other groups.
Conclusions: CD86-silenced-DCs induced immune tolerance of rat xeno-islets in recipient diabetic mice with up-regulated peripheral blood CD4(+)CD25(+)T cells.
Keywords: CD80/CD86; Dendritic cells; Diabetes; Immune tolerance; Pancreatic islet transplantation; Xenotransplantation.
Copyright © 2016 Elsevier GmbH. All rights reserved.
Similar articles
-
[Effect of CD86 Gene Modified Recipient Dendritic Cell on Mix Cultured Donor-derived Islet with Recipient-derived Lymphocyte in vitro].Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Jul;46(4):501-7. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015. PMID: 26480647 Chinese.
-
Trogocytosis of CD80 and CD86 by induced regulatory T cells.Cell Mol Immunol. 2012 Mar;9(2):136-46. doi: 10.1038/cmi.2011.62. Epub 2012 Feb 6. Cell Mol Immunol. 2012. PMID: 22307040 Free PMC article.
-
Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.J Biol Chem. 2014 Mar 14;289(11):7747-62. doi: 10.1074/jbc.M113.519686. Epub 2014 Jan 10. J Biol Chem. 2014. PMID: 24415757 Free PMC article.
-
Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.Immunol Rev. 2006 Aug;212:314-29. doi: 10.1111/j.0105-2896.2006.00422.x. Immunol Rev. 2006. PMID: 16903923 Review.
-
Regulation of self-tolerance by CD80/CD86 interactions.Curr Opin Immunol. 1997 Dec;9(6):858-62. doi: 10.1016/s0952-7915(97)80190-2. Curr Opin Immunol. 1997. PMID: 9492990 Review.
Cited by
-
Malaria: Factors affecting disease severity, immune evasion mechanisms, and reversal of immune inhibition to enhance vaccine efficacy.PLoS Pathog. 2025 Jan 23;21(1):e1012853. doi: 10.1371/journal.ppat.1012853. eCollection 2025 Jan. PLoS Pathog. 2025. PMID: 39847577 Free PMC article. Review.
-
A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses.Sci Rep. 2022 Jul 1;12(1):11185. doi: 10.1038/s41598-022-15455-5. Sci Rep. 2022. PMID: 35778468 Free PMC article.
-
Immune landscape and response to oncolytic virus-based immunotherapy.Front Med. 2024 Jun;18(3):411-429. doi: 10.1007/s11684-023-1048-0. Epub 2024 Mar 8. Front Med. 2024. PMID: 38453818 Review.
-
MIS416 as a siRNA Delivery System with the Ability to Target Antigen-Presenting Cells.Nucleic Acid Ther. 2018 Aug;28(4):225-232. doi: 10.1089/nat.2017.0695. Epub 2018 Jun 12. Nucleic Acid Ther. 2018. PMID: 29893623 Free PMC article.
-
Immunomodulatory Effects of Nanoparticles on Dendritic Cells in a Model of Allergic Contact Dermatitis - Importance of PD-L2 Expression.Res Sq [Preprint]. 2023 Jul 12:rs.3.rs-3069059. doi: 10.21203/rs.3.rs-3069059/v1. Res Sq. 2023. Update in: Sci Rep. 2023 Sep 25;13(1):15992. doi: 10.1038/s41598-023-42797-5. PMID: 37503107 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous